Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.
Int J Mol Sci
; 16(2): 3213-25, 2015 Feb 02.
Article
in En
| MEDLINE
| ID: mdl-25648321
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Genetic Variation
/
Interferons
/
Hepatitis C
/
Apoptosis
/
Hepacivirus
/
Bcl-X Protein
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Mol Sci
Year:
2015
Type:
Article
Affiliation country:
Denmark